ArticleResearch square2026
Robust and Interpretable Metagenomic Modeling Through Structure-Aware Multi-View Learning and Attribution-Guided Biological Insight.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Integrative modeling of metagenomic and clinical data can advance the study of host phenotypes, but remains challenged by cross-view heterogeneity, uncertain generalizability, and poor interpretability. We developed SAMECAT (Structure-Aware Metagenomics multi-viEw Contrastive AlignmenT), a structure-aware deep learning framework that integrates species-level shotgun metagenomic profiles with mixed-type clinical covariates through view-specific encoders, clustering-informed contrastive alignment, and adaptive representation fusion. Using two independent Louisiana Osteoporosis Study datasets generated through distinct sequencing and bioinformatics pipelines (development n = 1,990; external evaluation n = 481), we evaluated SAMECAT for bone mineral density prediction at four skeletal sites. SAMECAT consistently outperformed single-view models, naive concatenation, alternative deep learning integration approaches, and established machine learning baselines, with performance gains largely preserved in cross-pipeline external evaluation. To improve biological interpretability, we developed a stability-oriented interpretation workflow that aggregates individually low-magnitude and diffusely distributed feature attributions into structured modules, revealing reproducible site-dependent patterns, coherent functional themes, and representative hub taxa. SAMECAT thus provides a robust and interpretable framework for multi-view metagenomic modeling of microbiome-associated host phenotypes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.